تحلیل اختیاری محصول
با اجازه شما، از تحلیلهای محدود و حریمخصوصیمحور استفاده میکنیم تا مسیرهای پژوهشی مؤثر را بشناسیم. از ردیاب تبلیغاتی یا بازپخش نشست استفاده نمیکنیم. این انتخاب را میتوانید در تنظیمات تغییر دهید. بخوانید سیاست حفظ حریم خصوصی.
EPAM Systems, Inc.'s published Strong Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $6.3B | |
|---|---|---|
| Revenue (ttm) | 5.6B | |
| Net income (ttm) | 401.7M | |
| EPS (ttm) | $7.39 | |
| Shares out | 51.6M | |
| P/E (trailing) | 18.4x | |
| P/E (forward) | 8.3x | |
| Volume | 301,910 | |
| Beta | 1.39 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $3.76B | $4.82B | $4.69B | $4.73B | $5.46B | +9.8% |
| Gross profit | $1.27B | $1.54B | $1.43B | $1.45B | $1.45B | +3.3% |
| Operating income | $542.3M | $573.0M | $501.2M | $544.6M | $520.0M | -1.0% |
| Net income | $481.7M | $419.4M | $417.1M | $454.5M | $377.7M | -5.9% |
| EPS (diluted) | $8.15 | $7.09 | $7.06 | $7.84 | $6.72 | -4.7% |
| EBITDA | $680.3M | $647.3M | $659.9M | $711.5M | $671.7M | -0.3% |
| R&D | — | — | — | — | — | — |
| SG&A | $648.7M | $872.8M | $815.1M | $816.3M | $928.7M | +9.4% |
Recent company headlines from major financial publishers.
Enterprise digital transformation accelerates as clients shift from experimental pilots to multi-million dollar production deployments of AI-native platforms. Revenue growth accelerates toward 11.0% to 13.0%, while operating margins expand toward 17.5% driven by delivery automation and higher-value modernization consulting. This path yields a fair value estimate of $266.26.
The modal expected path reflects steady execution through the current cyclical digestion. Revenue growth expands from 3.7% in FY2026 to 7.0% to 7.5% over the medium term, with non-GAAP operating margins normalizing from 15.8% in FY2026 toward 12.5% to 13.5% over time. Reinvestment requirements remain modest at 12% to 20% of NOPAT, supporting steady earnings growth and producing our committee fair value midpoint of $188.31.
| Ke ↓ / g → | 1.5% | 1.8% | 2.0% | 2.3% | 2.5% |
|---|---|---|---|---|---|
| 9.2% | $200 | $203 | $206 | $209 | $212 |
| 9.7% | $192 | $194 | $196 | $199 | $202 |
| 10.2% | $184 | $186 | $188 | $191 | $193 |
| 10.7% | $177 | $179 | $181 | $183 | $185 |
| 11.2% | $171 | $173 | $174 | $176 | $178 |
Upcoming earnings date and setup when available.
رتبهای که نسخهٔ پژوهشی منتشرشدهٔ هر ماه داشت. رتبه قیمت در تاریخ تحلیل را با ارزش منصفانه مقایسه میکند و سابقهای از درستی یا نادرستی ارزیابی نیست.
| سال | دی | بهمن | اسفند | فروردین | اردیبهشت | خرداد | تیر | مرداد | شهریور | مهر | آبان | آذر |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
